SNDX·87164F105·US·equity·Healthcare - Biotechnology-13D/G
SNDX (SYNDAX PHARMACEUTICALS INC) is held by 132 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($192.8M), GOLDMAN SACHS GROUP INC ($116.7M), STATE STREET CORP ($103.5M). Net institutional sentiment: Mixed.
See how SNDX's score breaks down across 4 SEC sources
Showing 1-20 of 139
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer